{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:12:54Z","timestamp":1791231174564,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005681","name":"Genesis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005681","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.clml.2021.01.008","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T02:37:09Z","timestamp":1610937429000},"page":"361-367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Overweight\/Obesity and Monoclonal Gammopathy of Undetermined Significance"],"prefix":"10.1016","volume":"21","author":[{"given":"Rebecca","family":"Georgakopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeliki","family":"Andrikopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros N.","family":"Sergentanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oraianthi","family":"Fiste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Zagouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gavriatopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora","family":"Psaltopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstathios","family":"Kastritis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Terpos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meletios-Athanasios","family":"Dimopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 4","key":"10.1016\/j.clml.2021.01.008_bib1","doi-asserted-by":"crossref","first-page":"iv52","DOI":"10.1093\/annonc\/mdx096","article-title":"Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Moreau","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2021.01.008_bib2","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"354","author":"Kyle","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2021.01.008_bib3","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0140-6736(10)60482-5","article-title":"Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study","volume":"375","author":"Dispenzieri","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.clml.2021.01.008_bib4","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group","volume":"121","author":"Kyle","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2021.01.008_bib5","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2141.2006.06235.x","article-title":"Monoclonal gammopathy of undetermined significance","volume":"134","author":"Kyle","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2021.01.008_bib6","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1182\/blood-2013-10-532283","article-title":"Inherited genetic susceptibility to monoclonal gammopathy of unknown significance","volume":"123","author":"Weinhold","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.01.008_bib7","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1373\/clinchem.2017.277376","article-title":"Obesity and cancer: evidence, impact, and future directions","volume":"64","author":"Colditz","year":"2018","journal-title":"Clin Chem"},{"key":"10.1016\/j.clml.2021.01.008_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.metabol.2018.11.001","article-title":"Obesity and cancer risk: emerging biological mechanisms and perspectives","volume":"92","author":"Avgerinos","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.clml.2021.01.008_bib9","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1158\/1055-9965.EPI-16-0762-T","article-title":"Young adult and usual adult body mass index and multiple myeloma risk: a pooled analysis in the International Multiple Myeloma Consortium (IMMC)","volume":"26","author":"Birmann","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clml.2021.01.008_bib10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.critrevonc.2016.02.011","article-title":"Food of animal origin and risk of non-Hodgkin lymphoma and multiple myeloma: a review of the literature and meta-analysis","volume":"100","author":"Caini","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.clml.2021.01.008_bib11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/01635581.2013.761255","article-title":"Meat, milk and risk of lymphoid malignancies: a case\u2013control study in Uruguay","volume":"65","author":"De Stefani","year":"2013","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.clml.2021.01.008_bib12","first-page":"1307","article-title":"Fish consumption and risk of myeloma: a meta-analysis of epidemiological studies","volume":"26","author":"Wang","year":"2015","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.clml.2021.01.008_bib13","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1080\/10428194.2017.1339873","article-title":"Consumption of fruits, vegetables, and risk of hematological malignancies: a systematic review and meta-analysis of prospective studies","volume":"59","author":"Sergentanis","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2021.01.008_bib15","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S0025-6196(11)61086-0","article-title":"Monoclonal gammopathy of undetermined significance: genetic vs environmental etiologies [editorial]","volume":"82","author":"Munshi","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clml.2021.01.008_bib16","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1182\/blood-2005-08-3449","article-title":"Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States","volume":"107","author":"Landgren","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.01.008_bib17","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/leu.2010.60","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management","volume":"24","author":"Kyle","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2021.01.008_bib18","first-page":"785","article-title":"Increased incidence of monoclonal gammopathy of undetermined significance in blacks and its age-related differences with whites on the basis of a study of 397 men and one woman in a hospital setting","volume":"116","author":"Singh","year":"1990","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.clml.2021.01.008_bib19","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.clml.2021.01.008_bib20","author":"Wells"},{"key":"10.1016\/j.clml.2021.01.008_bib21","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.clml.2021.01.008_bib22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3892\/etm_00000041","article-title":"Curcumin for the prevention of progression in monoclonal gammopathy of undetermined significance: a word of caution [review]","volume":"1","author":"Vermorken","year":"2010","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.clml.2021.01.008_bib23","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1177\/0148607185009005621","article-title":"Monoclonal gammopathy associated with Crohn\u2019s disease during treatment with total parenteral nutrition","volume":"9","author":"Nanji","year":"1985","journal-title":"J\u00a0Parenter Enter Nutr"},{"key":"10.1016\/j.clml.2021.01.008_bib24","first-page":"229","article-title":"Hyperimmunoglobulinemia E and efficacy of elimination diet in two patients with Schnitzler syndrome","volume":"46","author":"Kolkhir","year":"2014","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.clml.2021.01.008_bib26","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s00256-016-2425-4","article-title":"Abdominal adipose tissue in MGUS and multiple myeloma","volume":"45","author":"Veld","year":"2016","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.clml.2021.01.008_bib27","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/ajh.24355","article-title":"Reappraisal of risk factors for monoclonal gammopathy of undetermined significance","volume":"91","author":"Boursi","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2021.01.008_bib28","first-page":"626","article-title":"Effect of statins, smoking and obesity on progression of monoclonal gammopathy of undetermined significance: a case\u2013control study","volume":"89","author":"Thompson","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2021.01.008_bib29","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1182\/blood-2010-01-262394","article-title":"Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women","volume":"116","author":"Landgren","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.01.008_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206047","article-title":"Dietary intake is associated with risk of multiple myeloma and its precursor disease","volume":"13","author":"Thordardottir","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.clml.2021.01.008_bib31","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1007\/s00277-019-03825-5","article-title":"Socioeconomic position is positively associated with monoclonal gammopathy of undetermined significance in a population-based cohort study","volume":"98","author":"Schmidt","year":"2019","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2021.01.008_bib32","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/leu.2014.34","article-title":"Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12 482 persons from the national health and nutritional examination survey","volume":"28","author":"Landgren","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2021.01.008_bib33","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1182\/bloodadvances.2017007609","article-title":"Obesity and risk of monoclonal gammopathy of undetermined significance and progression to multiple myeloma: a population-based study","volume":"1","author":"Thordardottir","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.clml.2021.01.008_bib34","doi-asserted-by":"crossref","first-page":"e618","DOI":"10.1038\/bcj.2017.97","article-title":"Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12372 individuals 10-49 years old: a population-based study from the National Health and Nutrition Examination Survey","volume":"7","author":"Landgren","year":"2017","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.clml.2021.01.008_bib35","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw264","article-title":"Obesity and the transformation of monoclonal gammopathy of undetermined significance to multiple myeloma: a population-based cohort study","volume":"109","author":"Chang","year":"2017","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clml.2021.01.008_bib36","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1182\/blood-2011-01-330407","article-title":"Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease","volume":"118","author":"Fowler","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.01.008_bib37","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/oby.21894","article-title":"Circulating adiponectin levels differ between patients with multiple myeloma and its precursor disease","volume":"25","author":"Hofmann","year":"2017","journal-title":"Obesity"},{"key":"10.1016\/j.clml.2021.01.008_bib38","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/leu.2011.368","article-title":"Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites","volume":"26","author":"Greenberg","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2021.01.008_bib39","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/bjh.12935","article-title":"Body size and multiple myeloma mortality: a pooled analysis of 20 prospective studies","volume":"166","author":"Teras","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2021.01.008_bib41","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJMoa1508808","article-title":"Clonal immunoglobulin against lysolipids in the origin of myeloma","volume":"374","author":"Nair","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2021.01.008_bib42","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejim.2018.05.033","article-title":"The adipose organ and multiple myeloma: impact of adipokines on tumor growth and potential sites for therapeutic intervention","volume":"53","author":"Allegra","year":"2018","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.clml.2021.01.008_bib43","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1038\/leu.2014.112","article-title":"PKA\/AMPK signaling in relation to adiponectin\u2019s antiproliferative effect on multiple myeloma cells","volume":"28","author":"Medina","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2021.01.008_bib44","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1042\/cs1030137","article-title":"Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population","volume":"103","author":"Yamamoto","year":"2002","journal-title":"Clin Sci"},{"key":"10.1016\/j.clml.2021.01.008_bib45","doi-asserted-by":"crossref","first-page":"R1220","DOI":"10.1152\/ajpregu.00397.2004","article-title":"Adiponectin inhibits LPS-induced NF-\u03baB activation and IL-6 production and increases PPAR\u03b32 expression in adipocytes","volume":"288","author":"Ajuwon","year":"2005","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.clml.2021.01.008_bib46","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1016\/j.ajpath.2016.07.012","article-title":"Adipocyte-lineage cells support growth and dissemination of multiple myeloma in bone","volume":"186","author":"Trotter","year":"2016","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clml.2021.01.008_bib47","doi-asserted-by":"crossref","first-page":"86075","DOI":"10.18632\/oncotarget.13342","article-title":"Adipocytes secreted leptin is a pro-tumor factor for survival of multiple myeloma under chemotherapy","volume":"7","author":"Yu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.clml.2021.01.008_bib48","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1600-0609.2009.01311.x","article-title":"Abnormal adipokine levels and leptin-induced changes in gene expression profiles in multiple myeloma","volume":"83","author":"Reseland","year":"2009","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clml.2021.01.008_bib49","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/bjc.2017.282","article-title":"Circulating resistin levels and risk of multiple myeloma in three prospective cohorts","volume":"117","author":"Santo","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clml.2021.01.008_bib50","first-page":"193","article-title":"Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case\u2013control study","volume":"20","author":"Dalamaga","year":"2009","journal-title":"Cancer Causes Control"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265021000094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265021000094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:35:54Z","timestamp":1761870954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265021000094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S2152265021000094"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2021.01.008","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overweight\/Obesity and Monoclonal Gammopathy of Undetermined Significance","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2021.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}